葡萄糖皮质类药物治疗和风湿性疾病的不良传染事件
Valeria Rella1, Cinzia Rotondo1, Raffaele Barile1
1Rheumatology Unit, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.
Hospital practice (1995)
|October 30, 2024
概括
在类风湿性疾病中使用葡萄糖皮质类药物会增加感染风险. 仔细管理,考虑剂量,持续时间和患者因素,对于最大限度地降低这种风险至关重要.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 风湿性疾病本质上增加了由于免疫功能障碍和疾病活性而导致的感染风险.
- 葡萄糖皮质类药物虽然是有效的抗炎和免疫抑制剂,但具有显著的传染性副作用.
- 医生必须了解葡萄糖皮质激素机制,副作用和患者特异性因素,以确保安全使用.
研究的目的:
- 在风湿性疾病中审查与葡萄糖皮质体治疗相关的传染风险.
- 强调适当的药物管理和疾病背景在管理传染性副作用方面的重要性.
- 分析葡萄糖皮质醇剂量,持续时间和感染风险之间的关系.
主要方法:
- 随机对照试验的系统审查.
- 关于在自身免疫/风湿性疾病中使用葡萄糖皮质体的观察性研究的分析.
- 与葡萄糖皮质醇剂量和治疗持续时间有关的感染风险的评估.
主要成果:
- 在类风湿性疾病中,葡萄糖皮质体治疗与感染性并发症的增加有关.
- 感染风险取决于剂量和持续时间,强调需要明智的处方.
- 患者的并发病和疾病活动也会影响整体感染风险概况.
结论:
- 优化皮质糖类药物管理对于减轻风湿性疾病患者感染风险至关重要.
- 对葡萄糖皮质醇毒性和患者特异性因素的全面了解对于安全的临床实践至关重要.
- 尽量减少累积的皮质糖类药物暴露,可以显著降低严重感染的可能性.
相关概念视频
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
97
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
97
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
143
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
143
01:29Pulmonary Tuberculosis I
220
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
220
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
223
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
223
01:21Rheumatic Heart Disease III: Medical Management
3
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
3
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
117
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
117